Skip to main content

Share story

Robotics

Waymo asks DoorDash drivers to shut doors of its self-driving cars

Waymo asks DoorDash drivers to shut doors of its self-driving cars Image: Primary
Waymo and DoorDash confirmed to TechCrunch that the companies have a pilot program in Atlanta to address cases in which a passenger leaves a Waymo vehicle door open. A Reddit post described one DoorDash driver who received an offer of 6.25 dollars to drive less than one mile to a Waymo car and close its door, with an additional 5 dollars paid after verified completion. The companies said the notifications go to nearby Dashers when a door is left ajar and prevents the vehicle from departing on its next trip. Waymo and DoorDash said in a joint response that the program helps return vehicles to service quickly. An open door leaves the car immobile and unable to accept more rides, and the vehicle could also block traffic, they noted. The door-closing arrangement began earlier this year. Waymo said future vehicles will have automated door closures.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from TechCrunch and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.